| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $288.8M | $272.7M | $304.2M |
| YoY Revenue Growth % | +5.9% | -10.4% | — |
| Gross Profit | $251.0M | $229.2M | — |
| Gross Margin % | 86.9% | 84.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $53.8M | $40.8M | $81.0M |
| Operating Margin % | 18.6% | 15.0% | 26.6% |
| Net Income (GAAP) | $52.3M | $46.9M | $90.3M |
| EBITDA (Normalized) | $53.9M | $40.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $21.0M | $26.8M | $19.8M |
| Capital Expenditures (CapEx) | $30.0K | $35.0K | — |
| Free Cash Flow (FCF) | $21.0M | $26.8M | $19.8M |
| FCF Margin % | 7.3% | 9.8% | 6.5% |
| Return on Invested Capital (ROIC %) | 80.4% | 95.0% | — |
| Cash & Short-Term Equivalents | $82.3M | $69.5M | — |
| Total Debt (Short + Long Term) | $0 | $4.8M | — |
| Total Stockholders' Equity | $135.2M | $82.4M | — |